Ming-Ju Hsieh Selected Research

Carcinogenesis

1/2018	WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
1/2018	Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan.
1/2017	Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
1/2016	ADAMTS14 Gene Polymorphism and Environmental Risk in the Development of Oral Cancer.
8/2014	Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
3/2009	The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Ju Hsieh Research Topics

Disease

89	Neoplasms (Cancer) 04/2024 - 04/2003
44	Mouth Neoplasms (Oral Cancer) 04/2024 - 01/2012
35	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2010
24	Hepatocellular Carcinoma (Hepatoma) 04/2019 - 01/2012
20	Squamous Cell Carcinoma of Head and Neck 04/2024 - 10/2014
19	Nasopharyngeal Carcinoma 04/2024 - 01/2014
16	Heart Arrest (Cardiac Arrest) 12/2023 - 11/2015
13	Stroke (Strokes) 02/2024 - 05/2013
11	Lung Neoplasms (Lung Cancer) 12/2021 - 02/2002
9	Pneumothorax 01/2024 - 11/2002
9	Adenocarcinoma of Lung 12/2022 - 01/2016
7	Carcinoma (Carcinomatosis) 11/2020 - 01/2014
6	Liver Neoplasms (Liver Cancer) 04/2024 - 06/2014
6	Wounds and Injuries (Trauma) 03/2024 - 11/2015
6	COVID-19 11/2023 - 12/2021
6	Pain (Aches) 05/2023 - 11/2015
6	Out-of-Hospital Cardiac Arrest 01/2022 - 01/2018
6	Carcinogenesis 01/2018 - 03/2009
6	Esophageal Squamous Cell Carcinoma 01/2018 - 03/2009
5	Hemorrhage 01/2024 - 04/2003
5	Drowning 12/2023 - 12/2022
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 12/2009
5	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2018 - 03/2015
5	Esophageal Neoplasms (Esophageal Cancer) 01/2014 - 10/2005
5	Tracheal Stenosis 12/2009 - 06/2005
4	Leukemia 12/2023 - 01/2014
4	Infections 01/2023 - 01/2016
4	Ischemic Stroke 09/2022 - 11/2014
4	Osteosarcoma (Osteogenic Sarcoma) 03/2019 - 03/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2019 - 01/2016
3	Lymphatic Metastasis 04/2024 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 11/2021
3	Burns 01/2022 - 06/2005
3	Breast Neoplasms (Breast Cancer) 03/2019 - 08/2010
3	Pneumonia (Pneumonitis) 07/2015 - 06/2008
3	Airway Obstruction (Choking) 01/2011 - 04/2003

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2010
11	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 08/2010
10	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2016
9	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 01/2014
9	Mitogen-Activated Protein KinasesIBA 08/2021 - 01/2012
9	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2020 - 01/2012
8	CaspasesIBA 12/2022 - 01/2014
7	Messenger RNA (mRNA)IBA 11/2023 - 03/2009
6	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2017 - 01/2012
5	AlkaloidsIBA 08/2023 - 10/2019
5	pterostilbeneIBA 01/2017 - 01/2014
4	Coloring Agents (Dyes)IBA 01/2024 - 12/2009
4	Long Noncoding RNAIBA 12/2022 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 03/2009
4	dehydrocrenatidineIBA 03/2022 - 05/2021
4	Matrix Metalloproteinases (MMPs)IBA 11/2020 - 06/2016
4	coronarin DIBA 08/2020 - 12/2017
4	Vincristine (Oncovin)FDA LinkGeneric 03/2020 - 04/2015
4	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2020 - 01/2015
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 04/2018
4	Peptide Hydrolases (Proteases)FDA Link 09/2019 - 01/2013
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2017 - 01/2012
3	Oxygen (Dioxygen)IBA 01/2023 - 12/2019
3	Vasopressins (Vasopressin)IBA 01/2023 - 12/2022
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 12/2022
3	Death Domain ReceptorsIBA 03/2022 - 08/2017
3	AmphiregulinIBA 01/2022 - 10/2019
3	Cadherins (E-Cadherin)IBA 05/2021 - 03/2016
3	Tumor Biomarkers (Tumor Markers)IBA 11/2020 - 01/2014
3	MelatoninIBA 03/2020 - 01/2017
3	FlavonoidsIBA 01/2020 - 08/2017
3	GelatinIBA 10/2019 - 10/2017
3	cathepsin SIBA 09/2019 - 01/2017
3	celastrolIBA 05/2019 - 08/2017
3	norcantharidinIBA 03/2018 - 01/2012
3	polyphyllin VIIIBA 01/2018 - 10/2016
3	hispolonIBA 01/2018 - 10/2014
3	dehydroandrographolideIBA 01/2017 - 10/2015
3	dioscinIBA 01/2017 - 01/2012
3	glabridinIBA 04/2016 - 01/2014
3	AntioxidantsIBA 06/2015 - 01/2014
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015 - 01/2012

Therapy/Procedure

18	Resuscitation 12/2023 - 11/2002
15	Cardiopulmonary Resuscitation (CPR) 12/2023 - 01/2019
11	Therapeutics 05/2023 - 01/2012
10	Drug Therapy (Chemotherapy) 12/2022 - 01/2014
5	Thrombectomy 02/2024 - 08/2010
5	Length of Stay 12/2016 - 06/2008
5	Chemoradiotherapy 03/2012 - 12/2009
5	Stents 01/2011 - 04/2003
4	Radiotherapy 11/2022 - 01/2019
4	First Aid (Aids, First) 01/2022 - 12/2019
4	Esophagectomy 01/2022 - 10/2005
4	Thrombolytic Therapy 10/2018 - 11/2014
4	Thoracotomy 01/2016 - 11/2003
3	Tourniquets 03/2024 - 12/2021
3	Critical Care (Surgical Intensive Care) 01/2024 - 01/2005
3	Immunotherapy 12/2023 - 01/2015
3	Defibrillators (Defibrillator) 09/2023 - 10/2020
3	Airway Management 01/2023 - 01/2018
3	Continuous Positive Airway Pressure 01/2023 - 12/2022
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 09/2012
3	Punctures 11/2021 - 01/2018
3	Operative Time 06/2016 - 11/2015